Natera - 10 Year Stock Price History | NTRA
- The all-time high Natera stock closing price was 177.00 on February 05, 2025.
- The Natera 52-week high stock price is 183.00, which is 5.5% above the current share price.
- The Natera 52-week low stock price is 68.03, which is 60.8% below the current share price.
- The average Natera stock price for the last 52 weeks is 122.86.
Natera Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 170.7347 | 160.6000 | 177.0000 | 158.3600 | 173.3900 | 9.53% |
2024 | 109.7520 | 61.9200 | 174.0000 | 59.2100 | 158.3000 | 152.71% |
2023 | 49.9957 | 38.4900 | 62.6400 | 36.5700 | 62.6400 | 55.94% |
2022 | 46.4666 | 91.3300 | 91.3300 | 28.1300 | 40.1700 | -56.99% |
2021 | 107.5655 | 96.3100 | 126.3600 | 86.0500 | 93.3900 | -6.16% |
2020 | 53.7034 | 33.2900 | 111.7400 | 17.2700 | 99.5200 | 195.40% |
2019 | 26.1781 | 12.9500 | 40.4000 | 11.3400 | 33.6900 | 141.33% |
2018 | 16.1340 | 9.4700 | 28.9600 | 8.7900 | 13.9600 | 55.28% |
2017 | 10.2984 | 11.8900 | 14.3100 | 7.5000 | 8.9900 | -23.23% |
2016 | 10.4886 | 10.3400 | 13.7900 | 6.6100 | 11.7100 | 8.43% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $23.122B | $1.083B |
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $151.685B | 28.04 |
Elevance Health (ELV) | United States | $90.559B | 11.84 |
Cencora (COR) | United States | $47.572B | 17.32 |
DiDi Global (DIDIY) | China | $22.844B | 0.00 |
ICON (ICLR) | Ireland | $16.164B | 14.40 |
Avantor (AVTR) | United States | $14.769B | 22.14 |
Revvity (RVTY) | United States | $14.502B | 24.32 |
BioMerieux (BMXMF) | France | $14.256B | 0.00 |
Viatris (VTRS) | United States | $13.010B | 4.01 |
Solventum (SOLV) | United States | $12.919B | 0.00 |
CochLear (CHEOY) | Australia | $12.848B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
Doximity (DOCS) | United States | $10.877B | 56.56 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
HealthEquity (HQY) | United States | $9.712B | 48.73 |
Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
Sotera Health (SHC) | United States | $3.909B | 20.91 |
Organon (OGN) | United States | $3.835B | 3.87 |
Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
Concentras Parent (CON) | United States | $2.958B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
PACS (PACS) | United States | $2.161B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
Progyny (PGNY) | United States | $1.859B | 37.64 |
GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
Premier (PINC) | United States | $1.821B | 11.08 |
GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Agilon Health (AGL) | United States | $1.351B | 0.00 |
CareDx (CDNA) | United States | $1.217B | 0.00 |
Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
Embecta (EMBC) | United States | $1.031B | 7.06 |
AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
SBC Medicals (SBC) | United States | $0.533B | 0.00 |
DocGo (DCGO) | United States | $0.501B | 18.89 |
Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
Enhabit (EHAB) | United States | $0.414B | 35.83 |
QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
MultiPlan (MPLN) | United States | $0.352B | 0.00 |
Nutex Health (NUTX) | United States | $0.323B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
LifeMD (LFMD) | United States | $0.270B | 0.00 |
Beauty Health (SKIN) | United States | $0.201B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
Biodesix (BDSX) | United States | $0.151B | 0.00 |
So-Young (SY) | China | $0.104B | 17.63 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
Oncology Institute (TOI) | United States | $0.067B | 0.00 |
ModivCare (MODV) | United States | $0.062B | 3.35 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |